Clinical Trial Update: Ca-Mg Butyrate in GWI [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating calcium-magnesium butyrate for Gulf War Illness and related symptoms (Chronic Fatigue and neurocognitive dysfunction) is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue Syndrome
• Gulf War Illness
• Neurocognitive Dysfunction

Drugs mentioned

• Ca-Mg Butyrate (calcium magnesium butyrate)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Gulf War Illness, Chronic Fatigue | Phase 2 | Status: RECRUITING